Sarah Kiely
Investor Relations Contact at PROQR THERAPEUTICS N.V.
Sarah Kiely active positions
| Companies | Position | Start | End |
|---|---|---|---|
| PROQR THERAPEUTICS N.V. | Investor Relations Contact | 30/09/2019 | - |
Career history of Sarah Kiely
Former positions of Sarah Kiely
| Companies | Position | Start | End |
|---|---|---|---|
| IMMUNOGEN, INC. | Investor Relations Contact | 30/04/2012 | 30/06/2019 |
| Public Communications Contact | 30/04/2012 | 30/06/2019 |
Training of Sarah Kiely
| Boston University | Masters Business Admin |
| Boston College | Undergraduate Degree |
Statistics
International
| United States | 4 |
| Netherlands | 2 |
Operational
| Investor Relations Contact | 2 |
| Public Communications Contact | 1 |
| Masters Business Admin | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| PROQR THERAPEUTICS N.V. | Health Technology |
| Private companies | 1 |
|---|---|
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded on March 27, 1981 and is headquartered in Waltham, MA. | Health Technology |
- Stock Market
- Insiders
- Sarah Kiely
- Experience
